Article info
PDFCorrespondence response
Effects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: ‘Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero’ by Satis et al
- Correspondence to Marie Wahren-Herlenius, Department of Medicine, Karolinska Institutet, Stockholm 171 77, Sweden; marie.wahren{at}ki.se
Citation
Effects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: ‘Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero’ by Satis et al
Publication history
- Received June 10, 2019
- Accepted June 15, 2019
- First published July 4, 2019.
Online issue publication
July 13, 2020
Article Versions
- Previous version (4 July 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.